Related references
Note: Only part of the references are listed.PACAP27 induces migraine-like attacks in migraine patients
Hashmat Ghanizada et al.
CEPHALALGIA (2020)
PACAP-38 and PACAP(6-38) Degranulate Rat Meningeal Mast Cells via the Orphan MrgB3-Receptor
Sara Hougaard Pedersen et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models
Kristian A. Haanes et al.
CEPHALALGIA (2019)
Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
Kristian Agmund Haanes et al.
CNS DRUGS (2019)
The effect of orofacial complete Freund's adjuvant treatment on the expression of migraine-related molecules
Tamas Kortesi et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Does inflammation have a role in migraine?
Lars Edvinsson et al.
NATURE REVIEWS NEUROLOGY (2019)
C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system
Jacob C. A. Edvinsson et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide
Cristina Moldovan Loomis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
A Phase-by-Phase Review of Migraine Pathophysiology
David W. Dodick
HEADACHE (2018)
PACAP and its receptors in cranial arteries and mast cells
Inger Jansen-Olesen et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Protective effects of PACAP in ischemia
Dora Reglodi et al.
JOURNAL OF HEADACHE AND PAIN (2018)
PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma
James A. Waschek et al.
JOURNAL OF HEADACHE AND PAIN (2018)
The pathophysiology of migraine: implications for clinical management
Andrew Charles
LANCET NEUROLOGY (2018)
CGRP as the target of new migraine therapies - successful translation from bench to clinic
Lars Edvinsson et al.
NATURE REVIEWS NEUROLOGY (2018)
Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine
Anne Luise Haulund Vollesen et al.
NEUROTHERAPEUTICS (2018)
PACAP38 and PAC1 receptor blockade: a new target for headache?
Eloisa Rubio-Beltran et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans
Simona Denise Frederiksen et al.
NEUROSCIENCE (2018)
Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP)
Angela J. Okragly et al.
CEPHALALGIA (2018)
Anatomy and immunochemical characterization of the non-arterial peptidergic diffuse dural innervation of the rat and Rhesus monkey: Implications for functional regulation and treatment in migraine
Frank L. Rice et al.
CEPHALALGIA (2017)
Hypothalamus as a mediator of chronic migraine Evidence from high-resolution fMRI
Laura H. Schulte et al.
NEUROLOGY (2017)
The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks
Laura H. Schulte et al.
BRAIN (2016)
Release of PACAP-38 in episodic cluster headache patients - an exploratory study
Bernadett Tuka et al.
JOURNAL OF HEADACHE AND PAIN (2016)
RNA Sequencing of Trigeminal Ganglia in Rattus Norvegicus after Glyceryl Trinitrate Infusion with Relevance to Migraine
Sara Hougaard Pedersen et al.
PLOS ONE (2016)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine
Simon Akerman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38
Faisal Mohammad Amin et al.
BRAIN (2014)
Expression and Characterization of Purinergic Receptors in Rat Middle Meningeal Artery-Potential Role in Migraine
Kristian Agmund Haanes et al.
PLOS ONE (2014)
Pituitary adenylate cyclase activating polypeptide and migraine
Alessandro S. Zagami et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
Deepak K. Bhatt et al.
CEPHALALGIA (2013)
Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients
Bernadett Tuka et al.
CEPHALALGIA (2013)
Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system
S. Eftekhari et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
Anthony J. Harmar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Potently Dilates Middle Meningeal Arteries: Implications for Migraine
Arsalan U. Syed et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery
Kayi Y. Chan et al.
CEPHALALGIA (2011)
Effects of PACAP on Oxidative Stress-Induced Cell Death in Rat Kidney and Human Hepatocyte Cells
Gabriella Horvath et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
Satellite glial cells in sympathetic and parasympathetic ganglia: In search of function
Menachem Hanani
BRAIN RESEARCH REVIEWS (2010)
Evidence for CGRP re-uptake in rat dura mater encephali
Saurabh Gupta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Pharmacokinetics and Brain Uptake of a Genetically Engineered Bifunctional Fusion Antibody Targeting the Mouse Transferrin Receptor
Ruben J. Boado et al.
MOLECULAR PHARMACEUTICS (2010)
Effects of PACAP on the oxidative stress-induced cell death in chicken pinealocytes is influenced by the phase of the circadian clock
Gabriella Horvath et al.
NEUROSCIENCE LETTERS (2010)
PACAP38 induces migraine-like attacks in patients with migraine without aura
Henrik Winther Schytz et al.
BRAIN (2009)
The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery
L. J. Boni et al.
CEPHALALGIA (2009)
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
D. Vaudry et al.
PHARMACOLOGICAL REVIEWS (2009)
Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine
A. Rahmann et al.
CEPHALALGIA (2008)
Impaired nerve regeneration and enhanced neuroinflarnmatory response in mice lacking pituitary adenylyl cyclase activating peptide
B. D. Armstrong et al.
NEUROSCIENCE (2008)
PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis
B. Racz et al.
REGULATORY PEPTIDES (2008)
Neuroprotection by endogenous and exogenous PACAP following stroke
Yun Chen et al.
REGULATORY PEPTIDES (2006)
Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors
Kazuhiko Tatemoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers
J. M. Hansen et al.
CEPHALALGIA (2006)
Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis
B Gasz et al.
PEPTIDES (2006)
Passage of VIP/PACAP/secretin family across the blood-brain barrier: Therapeutic effects
D Dogrukol-Ak et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia
K Suk et al.
BRAIN RESEARCH (2004)
Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion
MY Hou et al.
BRAIN RESEARCH (2003)
PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis
D Vaudry et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide
CT Eltorp et al.
CEPHALALGIA (2000)
Share Paper
